About
About
Purpose and values
Our leadership
Quality
Memberships
Commercial organizations
History
Products
Partnering
Partnering
Open Innovation Zentiva
Our Impact
Our Impact
Sustainability Report
Transparency
News
Careers
Careers
Careers in R&D
Careers in Manufacturing
Careers in Sales and Marketing
Careers in Corporate Functions
Students and graduates
Benefits
Contacts
Search...
Search...
Menu
About
Products
Partnering
Our Impact
News
Careers
Contacts
News
Newsroom
Zentiva signed an investment agreement and will launch a voluntary public purchase offer for Apontis Pharma
PUBLISHED
October 15, 2024
IN
Newsroom
Investment
M&A
Please refer to
www.zentiva-offer.com
for further information
Latest news
Zentiva at CPHI Frankfurt 2025
Zentiva is pleased to announce its participation in CPHI Worldwide 2025, taking place from 28 to 30 October at Messe Frankfurt, Germany. As one of the leading pharmaceutical events globally, CPHI brings together thousands of industry professionals to explore innovation, partnerships, and future-forward solutions in healthcare.
B2B
Growth
Innovation
Partnerships
Zentiva announces sale from Advent to GTCR
Prague, Czech Republic; London, UK; Chicago, US 11 September 2025 - Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.
CEO
Growth
Investors
Sustainability in Action
At Zentiva, our commitment to sustainability is rooted in tangible action and long-term impact. In the latest episode of our Sustainability Podcast series, we are honored to host Dr RK Nair, widely recognized as the Green Hero of India, whose pioneering work in reforestation has transformed landscapes and communities across the country.
Sustainability
Sustainability Podcast
Impact
Climate
Show all news